Defense contractor L3Harris raises 2025 outlook on steady demand
Shares of the company rose 2% in premarket trading.
Demand for arms and military equipment has ballooned in the face of a protracted Russia-Ukraine war and tensions in the Middle East, boosting sales at L3Harris and rivals.
The company, which makes solid rocket motors on the anti-tank Javelin missile system, expects about $21.75 billion in annual revenue, up from its prior forecast of between $21.4 billion and $21.7 billion.
It projected an adjusted profit of between $10.40 and $10.60 per share for the year, up from its previous expectation of $10.30 and $10.50.
The company's adjusted profit of $2.78 per share in the second quarter topped expectation of $2.50, according to data compiled by LSEG.
The defense contractor posted a revenue increase of 2.4% to $5.43 billion, beating estimates of $5.32 billion.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
25 minutes ago
- Reuters
Bristol Myers, Bain Capital form new company to develop immunology drugs
July 28 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab and private equity firm Bain Capital will launch an independent company focused on developing immunology drugs, backed by Bain's $300 million financing round, the companies said on Monday. The new company will work on five experimental drugs licensed from Bristol Myers, including a late-stage lupus treatment and a mid-stage psoriasis drug that has shown promise in trials. Bristol Myers will retain nearly 20% equity in the venture and is set to receive royalties and milestone payments based on the drugs' success. The collaboration allows the drugmaker to concentrate its immunology research on treatments aimed at resetting the immune system while ensuring the continued development of promising assets, the companies said. "These assets have significant potential, and we are confident that this new company will drive their development to ensure greater impact for patients," said Julie Rozenblyum, senior vice president of business development at Bristol Myers. Daniel Lynch, a seasoned pharmaceutical executive, will take on the roles of executive chairman and interim CEO of the new company, while Bristol Myers' chief research officer Robert Plenge is set to join the board alongside Bain Capital partners. Canada Pension Plan Investment Board also participated in the financing round.
Reuters
25 minutes ago
- Reuters
Universal Health Services beats quarterly profit estimates on higher medical care demand
July 28 (Reuters) - U.S. hospital operator Universal Health Services (UHS.N), opens new tab beat Wall Street estimates for second-quarter profit on Monday, driven by sustained demand for medical care services. Health insurers have flagged elevated demand and costs in individual Affordable Care Act (Obamacare) and Medicaid plans for low-income individuals, which could benefit hospital operators. Last week, larger peer HCA Healthcare (HCA.N), opens new tab beat quarterly profit estimates but saw its shares decline amid concerns over impending changes to Medicaid and Obamacare insurance plans under the Trump administration. Universal Health's same-facility adjusted admissions increased by 2% at acute care hospitals during the quarter, while admissions at behavioral healthcare facilities grew by 0.4%. The company now sees its 2025 revenue to be between $17.10 billion and $17.31 billion, compared to the previously expected range of $17.02 billion to $17.36 billion. Analysts, on average, expect 2025 revenue of $17.14 billion, according to data compiled by LSEG data. For the quarter ended June 30, the King Of Prussia, Pennsylvania-based company reported an adjusted profit of $5.43 per share, beating estimates of $4.92 per share. Investors are currently focused on how hospital operators will address potential tariffs affecting global supply chains for medical devices and surgical equipments. The sector is also preparing for the expiry of Obamacare subsidies next year, a change expected to impact patient coverage, raise insurance premiums and reduce enrollment numbers, potentially leaving hospitals responsible for increased uncompensated care costs.
Daily Mail
27 minutes ago
- Daily Mail
Trump's $400 million 'flying palace' gift from Qatar moves forward after 'bribe' backlash
The Pentagon and the Qatari government are close to finalizing the deal that will turn a $400 million 'flying palace' into President Donald Trump 's next Air Force One. CNN reported Monday on the language used in the agreement between Defense Secretary Pete Hegseth and his Qatari counterpart, which could still be tweaked ahead of a formal announcement. The transfer of the lavish Boeing 747-8 is being labeled an 'unconditional donation.' 'This donation is made in good faith and in the spirit of cooperation and mutual support between the parties,' the document said. 'Nothing in this MoU is, or shall be interpreted or construed as, an offer, promise, or acceptance of any form of bribery, undue influence, or corrupt practice.' Democrats - and even some Republicans - raised objections when the White House announced in May that the Qataris would be gifting the plane to the Americans, so that Trump could get a new Air Force One before the end of his second term. Eyebrows were further raised when it was announced that the plane would follow Trump to his presidential library after his term was done. Trump took time in mid-February to tour the Qatari aircraft, which was parked at the West Palm Beach airport, several miles down the road from Mar-a-Lago. Ahead of his trip to the Middle East in mid-May, which included a stop in Doha, Qatar, the framework for the deal became public. After the trip, the Americans officially accepted the gift. The initial agreement was signed by Hegseth and Qatar's deputy prime minister and minister of state for defense affairs, Saoud bin Abdulrahman Al-Thani on July 7. It's unclear when the final agreement will be signed off on. A Pentagon spokesperson told the Daily Mail on Monday, 'We have nothing to share on this.' The plane is currently sitting in San Antonio, Texas. The aircraft comes to the Defense Department 'as is,' meaning U.S. taxpayers will be paying for the upgrades needed to turn the 'flying palace' into a flying Situation Room. Hegseth has tried to keep the pricetag of the project quiet. During a Senate Appropriations Committee hearing in June, the Pentagon chief irritated Democratic Sen. Jack Reed by testifying that the timeline and the price of the project needed to remain classified. Hegseth justified the secrecy by saying it would 'ensure the safety and the security of the president of the United States.' The Department of Justice also hasn't released the memo, penned by Attorney General Pam Bondi, that outlines the legal justification allowing the Trump administration to accept the gift from the Qatari government. On Monday, the government transparency group, the Freedom of Press Foundation filed a Freedom of Information Act lawsuit to get access to that document. Bondi's memo reportedly argues that the Qatari donation is legally sound as long as the plane goes to Trump's presidential library at the end of his term. Trump is expected to build a presidential library in Florida, after changing his residency from his native New York to the Sunshine State in 2019. Early in his first term, the president negotiated the price of two new Boeing planes that would be used as Air Force Ones, but the project has been hampered by delays and cost overruns. Trump also designed a color scheme to mimic the one on his 'Trump Force One' private plane. When President Joe Biden came into office, he chose to maintain the traditional Kennedy-era color scheme on the new Air Force Ones. The president told the Daily Mail in February that 'no matter what' his new Air Force One would have his preferred color scheme.
